Antibiotics Market Revenue to Cross $40 billion by 2035 | Roots Analysis

Published: September 2023

According to a recently published report by Roots Analysis, the growing demand for effective therapeutic treatment options that can target a wide range of pathogenic bacterial strains is driving the antibiotics market growth

Antibiotics Industry Overview

The global antibiotics market is anticipated to grow at a CAGR of 1.2% from 2023-2035, reaching USD 41 billion by 2035.

Antibiotics, also known as antibacterial drugs, play a crucial role in the prevention and treatment of diverse groups of bacterial infections. Recent years have seen the approval of a range of new antibiotics, encompassing both broad-spectrum (effective against a wide array of bacteria) and narrow-spectrum (targeting specific bacterial strains) variants. These antibiotics address various infections such as anthrax, botulism, cholera, gonorrhea, meningitis, pneumonia, tetanus, tuberculosis, and syphilis. However, the development of antibiotic drugs faces challenges, including the rise of multidrug-resistant bacteria, shortages of antibiotics like penicillin and amoxicillin, and concerns regarding safety and efficacy. Clinical trials have demonstrated the enormous benefits offered by novel antibiotics for the treatment of a wide range of infections, presenting lucrative opportunities for the players engaged in the development of these therapies. With ongoing efforts from both industry and non-industry players and increasing worries about antimicrobial resistance, the global antibiotics market, or the global antibacterial drugs market, is anticipated to experience substantial growth in the forecast period.

Browse 210+ figures and 195+ market data tables spread across 175+ pages and detailed Table of Content on “Global Antibiotics Market - Distribution by Type of Drug Class, Target Disease Indication, Type of Therapy (Monotherapies and Combination Therapies), Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035” here:

Market Drivers

Various factors contribute to the market growth of antibiotics market. The growing incidence of infectious diseases worldwide is fueling the demand for effective and safe antibiotics to treat a wide range of bacterial infections. Additionally, the pharmaceutical industry's continuous focus on innovation has led to the development of novel antibiotics, marked by broader spectrum coverage, enhanced potency and reduced side effects. Further, the advent of novel approaches in antibiotic discovery, including synthetic biology and advanced computational methods, is contributing to breakthroughs in developing antibiotics with improved efficacy and the ability to combat antibiotic resistance. These market drivers collectively shape the evolving landscape of the global antibiotics market, emphasizing the critical role antibiotics play in public health and the ongoing efforts to address infectious diseases through innovative pharmaceutical solutions.

Market Restraints

Despite several drivers, antibiotics market is facing notable restraints, primarily from the emergence of multi multi-drug resistant bacteria and the high cost associated with research and development of safe and effective novel antibiotics. It is worth highlighting that antibiotic resistance, driven by bacterial evolution, poses a significant threat to the efficacy of existing medications, necessitating ongoing innovation to address evolving resistance mechanisms. Moreover, the considerable financial investment required for the research and development process serves as a substantial barrier, particularly for smaller pharmaceutical entities, potentially slowing down the pace of new antibiotic development. Overcoming these challenges demands collaborative efforts, including increased research investment, innovative funding models, and global cooperation in monitoring and regulating antibiotic use to ensure the sustained effectiveness of antibiotics in addressing bacterial infections on a global scale.

Growth Factors

Despite the challenges, several growth factors continue to drive the antibiotics market forward. One notable factor is the growing demand for novel broad spectrum antibiotics that can target multiple infectious diseases. Additionally, continuous evolution and innovation in research and development of antibiotics is another market driver propelling the growth of the antibiotics market in the forecast period. Moreover, the growing awareness of the global burden imposed by infectious diseases and antibiotic-resistant strains has spurred increased investments in antibiotic research. The expansion of collaborations between pharmaceutical companies, research institutions, and regulatory bodies further accelerates the development and approval of new antibiotics. Driven by the continuous efforts of both industry and non-industry players and growing concerns associated with antimicrobial resistance, the global antibiotics market / global antibacterial drugs market is likely to witness significant growth during the forecast period.

Antibiotics Market Segments

Based on the type of drug class, the market is segmented into cephalosporins, carbapenems, aminoglycosides, triazaacenaphthylenes, fluoroquinolones, tetracyclines, lipoglycopeptide, lincosamide and other drug classes.

  • The carbapenem based antibiotics are anticipated to capture majority share (29%) in the overall antibiotics market by 2035.
  • In fact, the carbapenem segment is likely to grow at a relatively higher CAGR of 17% during the forecast period.

Based on the target disease indication, the market is segmented into urinary tract infections, respiratory tract infections, dermatological infections, gastrointestinal infections, sexually transmitted infections / reproductive tract infections, hematological infections, cystitis, diabetic foot infections, ear infections and others.

  • The urinary tract infections segment led the antibiotics market, capturing the largest revenue share of close to 20% in 2023.
  • In fact, the urinary tract infections segment is likely to grow at a relatively higher CAGR of 20.5% during the forecast period.

Based on the type of therapy, the market is segmented into monotherapies and combination therapies.

  • The monotherapies segment led the antibiotics market, capturing the largest revenue share of over 80% in 2023.
  • In fact, the monotherapies segment is likely to grow at a relatively higher CAGR of 17% during the forecast period.

Based on the route of administration, the market is segmented into intravenous, oral and both.

  • The oral antibiotics are anticipated to lead the antibiotics market, capturing the largest revenue share of 37% in 2023.
  • The antibiotics designed to be administered via intravenous route is likely to grow at a relatively higher CAGR of 11.5% during the forecast period.

Based on the Regional Insights, the antibiotics market is segmented into North America, Europe, Asia-Pacific, MENA and Latin America.

  • North America is anticipated to hold the maximum share (61.5%) of the global antibiotics market in 2023.
  • In Europe, the antibiotics market is anticipated to demonstrate lucrative growth during the forecast period growing at a CAGR of 33%.

Key Companies Profiled

The antibiotics market report also includes detailed profiles of key players (listed below) that offer liquid biopsy products:

  • Bristol Myers Squibb
  • Daiichi Sankyo
  • GlaxoSmithKline
  • Melinta Therapeutics
  • Merck
  • Pfizer

You Can Download Free Sample PDF Copy of This Report At:

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Email: or


  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry